FitLife Brands Return on Investment 2012-2025 | FTLF
Current and historical return on investment (ROI) values for FitLife Brands (FTLF) over the last 10 years.
| FitLife Brands ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2025-09-30 | $0.01B | $0.07B | 20.75% |
| 2025-06-30 | $0.01B | $0.05B | 26.37% |
| 2025-03-31 | $0.01B | $0.05B | 29.21% |
| 2024-12-31 | $0.01B | $0.05B | 30.06% |
| 2024-09-30 | $0.01B | $0.04B | 28.07% |
| 2024-06-30 | $0.01B | $0.04B | 27.33% |
| 2024-03-31 | $0.01B | $0.04B | 26.49% |
| 2023-12-31 | $0.01B | $0.04B | 22.54% |
| 2023-09-30 | $0.01B | $0.03B | 28.28% |
| 2023-06-30 | $0.01B | $0.03B | 43.08% |
| 2023-03-31 | $0.01B | $0.03B | 75.00% |
| 2022-12-31 | $0.01B | 0.00% | |
| 2022-09-30 | $0.01B | 0.00% | |
| 2022-06-30 | $0.01B | 0.00% | |
| 2022-03-31 | $0.01B | 0.00% | |
| 2021-12-31 | $0.01B | 0.00% | |
| 2021-09-30 | $0.01B | 166.67% | |
| 2021-06-30 | $0.01B | 126.32% | |
| 2021-03-31 | $0.00B | 66.67% | |
| 2020-12-31 | $0.00B | $0.01B | 66.67% |
| 2020-09-30 | $0.00B | $0.01B | 100.00% |
| 2020-06-30 | $0.00B | $0.01B | 160.00% |
| 2020-03-31 | $0.00B | 200.00% | |
| 2019-12-31 | $0.00B | 100.00% | |
| 2019-09-30 | $0.00B | 100.00% | |
| 2019-06-30 | $0.00B | $0.00B | 50.00% |
| 2019-03-31 | $0.00B | $0.00B | 100.00% |
| 2018-12-31 | $0.00B | 0.00% | |
| 2018-09-30 | $-0.01B | 0.00% | |
| 2018-06-30 | $-0.01B | 0.00% | |
| 2018-03-31 | $-0.01B | -360.00% | |
| 2017-12-31 | $-0.01B | -180.00% | |
| 2017-09-30 | $0.00B | -25.81% | |
| 2017-06-30 | $0.00B | $0.01B | -18.60% |
| 2017-03-31 | $0.00B | $0.01B | 0.00% |
| 2016-12-31 | $0.00B | $0.01B | 8.33% |
| 2016-09-30 | $0.00B | $0.01B | 0.00% |
| 2016-06-30 | $0.00B | $0.01B | 0.00% |
| 2016-03-31 | $0.00B | $0.01B | -10.26% |
| 2015-12-31 | $0.00B | $0.01B | -22.86% |
| 2015-09-30 | $0.00B | $0.01B | -12.50% |
| 2015-06-30 | $0.00B | $0.01B | 0.00% |
| 2015-03-31 | $0.00B | $0.01B | 12.12% |
| 2014-12-31 | $0.00B | $0.01B | 24.24% |
| 2014-09-30 | $0.00B | $0.01B | 37.50% |
| 2014-06-30 | $0.00B | $0.01B | 25.81% |
| 2014-03-31 | $0.00B | $0.01B | 34.78% |
| 2013-12-31 | $0.00B | $0.01B | 53.33% |
| 2013-09-30 | $0.00B | $0.01B | 100.00% |
| 2013-06-30 | $0.00B | 0.00% | |
| 2013-03-31 | $0.00B | 0.00% | |
| 2012-12-31 | $0.00B | 0.00% | |
| 2012-09-30 | $0.00B | 0.00% | |
| 2012-06-30 | $0.00B | 0.00% | |
| 2012-03-31 | $0.00B | 0.00% | |
| 2011-12-31 | $0.00B | 0.00% | |
| 2011-09-30 | $0.00B | 0.00% | |
| 2011-06-30 | $0.00B | 0.00% | |
| 2011-03-31 | $0.01B | 0.00% | |
| 2010-12-31 | $0.01B | 0.00% | |
| 2010-09-30 | $0.01B | 0.00% | |
| 2010-06-30 | $0.01B | 0.00% | |
| 2010-03-31 | $0.01B | 0.00% | |
| 2009-12-31 | $0.01B | 0.00% | |
| 2009-06-30 | $0.01B | 0.00% | |
| 2009-03-31 | $0.00B | 0.00% | |
| 2008-09-30 | $0.00B | 0.00% | |
| 2008-06-30 | $0.00B | 0.00% | |
| 2008-03-31 | $0.00B | 0.00% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.133B | $0.064B |
| FitLife Brands, Inc. provides nutritional and fitness enhancement products for health-conscious consumers. The Company's product includes Pump Fuel, ACG3, Core Fuel, Embrace Extreme, Lipo Rush, Cardio Cuts, Dr. Detox, Dr. Cholesterol and Dr. Joints. It market and sells product directly to athletic facilities, gyms and independent retailers. Fitlife Brands, Inc., formerly known as Bond Laboratories Inc., is headquartered in Omaha, Nebraska. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $197.518B | 22.06 |
| EssilorLuxottica (ESLOY) | France | $154.739B | 0.00 |
| Stryker (SYK) | United States | $139.087B | 26.68 |
| Medtronic (MDT) | Ireland | $129.586B | 17.95 |
| Boston Scientific (BSX) | United States | $108.915B | 24.09 |
| Medline (MDLN) | United States | $59.170B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.091B | 0.00 |
| ResMed (RMD) | United States | $37.821B | 25.25 |
| Agilent Technologies (A) | United States | $36.458B | 23.10 |
| GE HealthCare Technologies (GEHC) | United States | $36.095B | 17.29 |
| Koninklijke Philips (PHG) | Netherlands | $30.881B | 18.33 |
| Terumo (TRUMY) | Japan | $20.046B | 22.65 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.948B | 11.66 |
| Insulet (PODD) | United States | $17.647B | 54.77 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.998B | 0.00 |
| Baxter (BAX) | United States | $11.448B | 9.24 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.922B | 28.49 |
| Demant (WILYY) | Denmark | $6.264B | 0.00 |
| Envista Holdings (NVST) | United States | $4.976B | 25.22 |
| Lantheus Holdings (LNTH) | United States | $4.461B | 13.59 |
| BillionToOne (BLLN) | United States | $3.924B | 0.00 |
| ICU Medical (ICUI) | United States | $3.647B | 23.16 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.122B | 14.73 |
| Haemonetics (HAE) | United States | $2.672B | 11.69 |
| Neogen (NEOG) | United States | $2.338B | 51.19 |
| Phibro Animal Health (PAHC) | United States | $2.088B | 18.40 |
| Perrigo (PRGO) | Ireland | $2.009B | 5.03 |
| LeMaitre Vascular (LMAT) | United States | $1.991B | 40.08 |
| QuidelOrtho (QDEL) | United States | $1.956B | 13.59 |
| Curaleaf Holdings (CURLF) | Canada | $1.649B | 0.00 |
| AtriCure (ATRC) | United States | $1.635B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.625B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.427B | 20.67 |
| Green Thumb Industries (GTBIF) | United States | $1.390B | 60.91 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.304B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $1.106B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.071B | 317.86 |
| InMode (INMD) | Israel | $0.902B | 9.89 |
| Tilray Brands (TLRY) | Canada | $0.888B | 0.00 |
| Valneva SE (VALN) | France | $0.834B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.798B | 0.00 |
| Omeros (OMER) | United States | $0.796B | 0.00 |
| CeriBell (CBLL) | United States | $0.763B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.570B | 13.61 |
| Brainsway (BWAY) | Israel | $0.459B | 78.10 |
| Verano Holdings (VRNO) | United States | $0.432B | 0.00 |
| Cerus (CERS) | United States | $0.413B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.394B | 0.00 |
| SNDL (SNDL) | Canada | $0.386B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.361B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.328B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.321B | 25.61 |
| Quanterix (QTRX) | United States | $0.279B | 0.00 |
| Evolus (EOLS) | United States | $0.279B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.240B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanuwave Health (SNWV) | United States | $0.212B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.206B | 18.45 |
| High Tide (HITI) | Canada | $0.205B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.202B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.195B | 57.33 |
| TerrAscend (TSNDF) | Canada | $0.188B | 0.00 |
| Accendra Health (ACH) | United States | $0.184B | 1.85 |
| Organigram Global (OGI) | Canada | $0.177B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.176B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.174B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.150B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.129B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.74 |
| MacroGenics (MGNX) | United States | $0.109B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.098B | 0.00 |
| Biote (BTMD) | United States | $0.097B | 4.24 |
| Exagen (XGN) | United States | $0.075B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 24.96 |
| Sharps Technology (STSS) | United States | $0.048B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 31.08 |
| Cytosorbents (CTSO) | United States | $0.039B | 0.00 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.40 |
| Jin Medical (ZJYL) | China | $0.025B | 0.00 |
| Bonk (BNKK) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.003B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |